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Type I collagen mediates melanoma cells invasion through upregulation of matrix metalloproteinases-1 and -2
(MMP-1 and -2) expression and activation. We investigated here the contribution of elastin-derived peptides (ED),
degradation products of elastin, the main component of elastic ﬁbers in melanoma cells invasion and MMP-1 and -2
expression. Our results evidenced fragmentation of elastin at the invasive front of melanoma, particularly in the
most invasive tumors where those ﬁbers nearly totally vanished. By electron microscopy, elastolysis was found to
occur mainly at the periphery of melanoma cells, where close contact between elastic ﬁbers and cells could be
noticed. Therefore, we showed in vitro that plating melanoma cells high tumorigenic potential on ED-coated dishes,
selectively enhanced MMP-2, as membrane-type MMP-1 (MT1-MMP) production and activation. Nevertheless, pro-
MMP-2 activation was not observed owing to the parallel increase in tissue inhibitor of metalloproteinase (TIMP)-2
expression. The effects of ED on melanoma cells were found to be mediated by splicing form of b-galactosidase (S-
Gal) occupancy, as being suppressed by lactose. Supplementing collagen lattices with ED led to consistent
activation of MMP-2 that can be attributed to TIMP-2 downregulation. Upregulation of MMP-2 activation by ED led to
enhanced melanoma cells invasion through S-Gal occupancy. Immunohistochemistry studies, conﬁrmed that S-
Gal expression was more prominent at the melanoma invasion site associated with a strong expression of MMP-2
and MT1-MMP. We hypothesize that ED following interactions with S-Gal elastin receptor can favor melanoma cells
invasion through a three-dimensional type I collagen matrix by upregulating MMP-2 activation.
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The incidence of melanoma significantly increased in recent
years and, at advanced stages, patients exhibit poor
outcome and reduced survival (Balch et al, 2001). Melano-
ma progression is a multifactorial process, and factors that
promote cells invasion through skin boundaries are con-
sidered to have a crucial importance (Herlyn et al, 2002).
Among those factors are neutral proteinases belonging to
the plasmin(ogen) and matrixins, that is, matrix metallopro-
teinase (MMP) families that interplay to initiate proteolytic
cascades and tissue destruction (Stetler-Stevenson and Yu,
2001). In human melanoma, the expression of collagenase-
1 (MMP-1), gelatinase A (MMP-2), collagenase-3 (MMP-13),
and membrane-type matrix metalloproteinase-1 (MT1-
MMP) was correlated with the stages of tumor progression
(Hofmann et al, 2000; Bodey et al, 2001). Although all MMP
can participate alone or in a synergistic fashion in matrix
breakdown, cell invasion is now considered to require the
catalytic machinery of cell-associated endopeptidases
(Seiki, 2002; Hotary et al, 2000); to that respect, the MT1-
MMP/MMP-2 system has been consistently involved in the
capacity of normal and transformed cells to cross distinct
matrix barriers and a series of recent investigations pointed
toward the crucial role of both enzymes in melanoma
invasiveness (Kurschat et al, 2002; Sounni et al, 2002). On a
protease basis, stroma reaction in melanoma depicts the
cross-talk between cancer cells and host cells and/or
matrix to initiate proteolytic cascades. For instance,
stromelysin-1 (MMP-3) expressed by activated fibroblasts
within tumor can activate MMP secreted from melanoma
cells as MMP-1, further facilitating the penetration of a type
I collagen substratum (Benbow et al, 1999). Regulation of
the MT1-MMP/MMP-2 system, in turn, is particularly
sensitive to cell–matrix interaction (Seltzer et al, 1994; Haas
et al, 1998). MMP-2 activation was reported to be triggered
by culturing melanoma cells within type I collagen lattices
(Kurschat et al, 1999; Ntayi et al, 2001). Besides fibrillar
collagens, human dermis contains a network of elastic
fibers (FE; Christiano and Uitto, 1994) that might also
influence melanoma progression. Elastin, the main amor-
phous component of those fibers, is synthesized by
fibroblasts as a tropoelastin precursor which undergoes
Abbreviations: BSA, bovine serum albumin; EBP, elastin-binding
protein; ED, elastin-derived peptides; FE, elastic fibers; FITC,
fluorescein isothiocyanate; FMC, 9-fluoromethoxycarbonyl; MMP,
matrix metalloproteinase; MT1-MMP, membrane-type MMP-1;
PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate;
S-Gal, splicing form of b-galactosidase; TIMP, tissue inhibitor of
metalloproteinase.
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lysyl oxidase-catalyzed cross-links formation in the extra-
cellular milieu (Toonkool et al, 2001). Such a reticulated
state, together with the extreme hydrophobicity of elastin,
makes it resistant to most proteolytic enzymes except
elastases (Jones and DeClerck, 1980; Werb et al, 1982)
Among matrixins, MMP-2 (gelatinase A), MMP-9 (gelatinase
B), MMP-7 (matrilysin), and MMP-12 (metalloelastase) have
been described to display elastinolytic activity (Shipley et al,
1996; Mecham et al, 1997). Interaction between elastin-
derived peptides (ED) and several cell types can trigger
several biologic responses in cancer cells (Lapis and Timar,
2002). They can stimulate the proliferation of astrocytoma
cells (Jung et al, 1998), the directed migration of melanoma
cell lines (Mecham et al, 1989) and the expression of MMP
by HT-1080 fibrosarcoma cells (Brassart et al, 1998; Huet
et al, 2002). Those effects are mediated through occupancy
of a cell-associated elastin-binding protein (EBP), which
was further identified as a spliced form b-galactosidase
(S-Gal) (Hinek et al, 1993; Privitera et al, 1998); such a
splicing introduces within b-galactosidase a 32-amino-acid
sequence presenting binding affinity for an X-G-X-X-p-G
module repeated severalfold in tropoelastin.
Here, we evidenced by immunohistochemistry a con-
spicuous degradation of FE at the tumor invasion front
where MT1-MMP and MMP-2 also accumulated. Also, our
in vitro experiments demonstrated that ED increased
melanoma cells invasion through a type I collagen matrix
by upregulating MMP-2 expression and activation.
Results
Melanoma invasion is associated with FE fragmenta-
tion Degradation of FE in normal skin, compared to that of
patients presenting melanoma, was analyzed histologically
using conventional orcein staining. Whatever the Breslow
index, FE were found to almost disappear within tumor (Fig
1B). In close contact to tumor cells at the invasive front of
thick melanoma, FE presented a fragmented thin appear-
ance (Fig 1C) or were virtually undetected (Fig 1D).
At the electron microscopy level, several contact areas
between cancer cells and FE could be demonstrated. Those
interactions between melanoma cell and elastin were
associated with peripheral elastolysis with fibers showing
a mottled structure (Fig 1E,F).
Inﬂuence of elastin fragments on proliferation and
MMP-1 or MMP-2 expression of human melanoma cell
lines The above-depicted in vivo observations prompted
us to investigate the influence of ED on the behavior of
melanoma cell lines. For that purpose we used two
melanoma cell lines, M1Dor and M3Da, previously reported
to secrete MMP in a direct relationship with their tumori-
genic potential into nude mice (Capon et al, 1999). We first
verified that both melanoma cell lines did express S-Gal (not
shown) and analyzed the effect of a soluble ED (k-elastin)
on melanoma cell proliferation. Supplementation of culture
medium with k-elastin (from 10 to 100 mg/mL) or k-
elastin coating had no effect on M1Dor and M3Da cells
proliferation.
We further examined the effect of k-elastin on the
secretion of MMP-2 and MMP-1 by melanoma cells.
M3Da and M1Dor cell lines were grown on plastic overnight
until adhesion, and k-elastin (50 mg/mL) was added to
serum-free culture medium. The production of MMP-2 and
MMP-1 was then analyzed by zymography and ELISA,
respectively. Figure 2A shows that levels of MMP-2 were
not modified when k-elastin was added to cell culture
medium.
Alternatively, melanoma cells were seeded on k-elastin-
coated dishes and conditioned media were analyzed by
zymography or by ELISA for MMP-2 and MMP-1 expres-
sion. M1Dor and M3Da cell lines displayed an apparent
increase in the secretion of latent MMP-2, whereas
activated forms of this enzyme were not detectable (Fig
2B). Nevertheless, as shown in Fig 2C, no MMP-2 activation
was obtained in the membrane extracts of melanoma cells
seeded on k-elastin-coated dishes. In contrast, no differ-
ence in pro-MMP-1 production by melanoma cells cultured
either on plastic or on k-elastin-coated plates could be
observed (Fig 2D).
To evaluate whether EBP can mediate the effects of
elastin peptides on MMP-2 production in highly invasive
melanoma cells, lactose was used as an inhibitory
compound. When preincubating melanoma cells with a
lactose solution (10 mM), the k-elastin-enhanced pro-MMP-
2 secretion was inhibited (Fig 2E). In addition, when seeding
melanoma cells on VGVAPG-coated plates, a ligand of EBP,
pro-MMP-2 production was also stimulated (Fig 2E).
Altogether, these data suggested that EBP mediated the
ED upregulation of pro-MMP-2 in melanoma cells.
Differential effects of ED on components of the MMP-2
activation system in highly invasive melanoma cells In
several cell systems, pro-MMP-2 activation depends on
MT1-MMP upregulation and activation, but is also governed
by the relative expression of TIMP-2 and integrin avb3.
Upon contact of M3Da cells with k-elastin, an increase in
both inactive 63-kDa and active 60-and 57-kDa forms of
MT1-MMP was observed (Fig 3A). Consistent with the lack
of pro-MMP-2 activation, processing of MT1-MMP to its
inactive 45-kDa species did not occur in the absence or
presence of k-elastin. Because overexpression of TIMP-2
could counterbalance the k-elastin-mediated upregulation
of MT1-MMP, the level of that inhibitor was analyzed by
reverse zymography. Figure 3B shows that k-elastin
stimulated the production of TIMP-2 and TIMP-1 by M3Da
cells while having no effect on M1Dor cells. In some cell
types, avb3-integrin has been also described as a partner of
the active matrix-degrading complex (MMP-2/TIMP-2/MT1-
MMP). Immunocytochemistry studies (not shown) revealed
that avb3-integrin was expressed in M1Dor and M3Da
melanoma cells. The less invasive M1Dor cells displayed,
however, a weaker staining pattern compared to the highly
invasive M3Da cell line. To characterize whether there was
any difference in the expression level of avb3-integrin
between plastic and elastin-coated culture conditions, flow
cytometry was performed. Figure 3C shows that plating
melanoma cells on a k-elastin substrate had no effect on
the avb3-integrin expression and suggests that this integrin
did not mediate ED effects.
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ED-enhanced melanoma cell invasiveness through type
I collagen is dependent on MMP-2 activation following
S-Gal occupancy The influence of k-elastin on melanoma
cells invasiveness was assessed by embedding cells into
collagen gels, containing or not k-elastin. Figure 4A shows
that the invasive capacity of M3Da cells was increased
(  30%) by k-elastin, whereas there was no difference in
the type I collagen invasive capacity of the less invasive
M1Dor cells, with or without k-elastin.
To examine the respective role of MMP-1 and MMP-2 in
elastin-enhanced M3Da cells invasion, the production of
latent and active forms of those enzymes was determined
by western blot and gelatin zymography. No significant
difference in MMP-1 production and activation were found
in collagen gel cultures containing or not k-elastin,
suggesting that the increase invasive capacity observed
with k-elastin is unrelated to enhanced secretion or
activation of MMP-1 (Fig 4B). In contrast, secretion and
activation of MMP-2 by M3Da cells were enhanced when
k-elastin was present into collagen gels (Fig 4C). As we
previously reported, culturing M3Da cells within collagen
gels led to MT1-MMP activation and processing to a 45-
kDa species; that has been also observed in the present
investigation, in absence and presence of k-elastin (not
shown). As mentioned above, MMP-2 activation process is
dependent on TIMP-2 expression. The TIMP-2 level, which
Figure 1
Fragmented appearance of elastic
fibers in melanoma lesions. Optical
microscopy: (A) Normal FE in the reticu-
lar dermis of a 20-y-old individual (orcein
staining). (B) Scanty and scattered FE
within an invasive melanoma tumor. (C)
Thin appearance of the degraded FE at
the invasive front of a tumor with a
Breslow index of 5.2 mm. (D) Total
absence of FE network in melanoma
(Breslow index 5.2 mm). Transmission
electron microscopy: Degraded FE at the
immediate vicinity of a melanoma cell (E)
and a fibroblast (F) at the invasive front of
the tumor. Scale bar: (A) 250 mm; (B–D)
500 mm; (E, F ) 500 mm.
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was previously shown to be lower in collagen lattices
compared to plastic, was determined by western blotting.
Figure 4D demonstrates that an additional reduction (1.7-
fold) in TIMP-2 production was found when cultures of
M3Da cells were performed into collagen lattices with
k-elastin (50 mg/mL).
Figure 2
Influence of ED on in vitro secretion of MMP-1 and MMP-2. (A) Melanoma cells were cultured on plastic in serum-free medium with or without
k-elastin, and the MMP-2 secretion was analyzed by gelatin zymography. (B) Melanoma cells were cultured on k-elastin-coated plates, and the
secretion of MMP-2 in conditioned medium was assessed by gelatin zymography. (C) The expression of MMP-2 in membrane extracts of melanoma
cells grown on k-elastin-coated plates was determined by gelatin zymography. (D) Samples from melanoma cells cultured either on plastic with or
without k-elastin or on k-elastin-coated plates for 48 h were quantified by ELISA for MMP-1 production; data are means  SEM of triplicate
experiments. (E) The role of EBP in the overproduction of pro-MMP-2 in response to k-elastin was studied by preincubating M3Da cells with lactose
before seeding on k-elastin-coated plates; conditioned media were then analyzed by gelatin zymography.
Figure 3
Effect of ED on MT1-MMP, TIMP-2, and avb3-integrin
expression. (A) Cell lysates from M3Da cells grown on
k-elastin were separated by SDS-polyacrylamide gel
electrophoresis under reducing conditions, and the expres-
sion and processing of MT1-MMP were determined by
western blot. (B) The production of TIMP-1 and TIMP-2 in
melanoma cells cultured on k-elastin-coated plates was
assessed by reverse zymography. (C) The expression of
avb3-integrin in melanoma cells cultured on plastic or on
k-elastin substrate was determined by fluorescence-acti-
vated cell sorting analysis; cells were incubated in the
presence of control non immune IgG (left) or LM609 avb3
antibody (right) and analyzed by flow cytometry.
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To confirm the role of the MMP-2 activation system in k-
elastin-enhanced collagen-invasive capacity of melanoma
cells, we used batimastat, a broad-spectrum MMP inhibitor.
Treatment of M3Da cells with batimastat resulted in marked
reduction (  63%) of their invasive behavior through type I
collagen gel containing k-elastin, associated with an
inhibition of MMP-2 activation (Fig 5A,B). Cells were further
treated with rec.TIMP-2, a natural and more selective
inhibitor of those MMP; TIMP-2 used at 80 ng per mL
inhibited M3Da cells invasiveness (  35%) and abrogated
MMP-2 activation (Fig 5A,B).
To evaluate the implication of EBP in the invasive
behavior of M3Da cells, they were embedded within
collagen lattices containing k-elastin, in the absence or
presence of either rabbit anti-S-Gal antibody or preimmune
rabbit IgG. Treatment with anti-S-Gal antibody resulted in
the inhibition of the k-elastin-enhanced melanoma cells
invasion process and inhibition of MMP-2 activation (Fig
5C,D). In addition, VGVAPG (200 mg/mL), the ligand-binding
domain of S-Gal, but also insoluble elastin (not shown),
could stimulate the invasive capacity of M3Da cells and
MMP-2 secretion and activation similarly as k-elastin (Fig
5C,D). These data argue for the direct implication of S-Gal in
mediating the increase of melanoma cells invasion through
type I collagen.
S-Gal and MMP expression in human melanoma The
close association between FE and some invasive melanoma
cells, suggested that interaction was mediated through
S-Gal present at the tumor cell surface. Using antibody
raised against a specific S-Gal sequence, originating from
alternate splicing of b-galactosidase, an intense staining
was observed in melanoma cells at the invasive front of the
tumor (Fig 6A).
As previously documented, MMP-2 and MT1-MMP were
detected in melanoma specimens (Fig 6B,C). An associa-
tion with the malignant phenotype could not be established,
because expression of MMP-2 was also observed in the
five nevi analyzed. Nevertheless, contrary to nevi where
staining was inconstantly observed mainly within the depth
of the lesion, melanoma was characterized by homoge-
neous intense expression of MMP-2 and MT1-MMP at
the invasive front (Fig 6B,C). Moreover, whereas MT1-MMP
was absent within nevi, its expression was clearly demon-
strated at the invasive front, particularly in melanomas with
a Breslow index of greater than 5 mm. Interestingly,
MMP-2 was found somewhat to be associated with FE
(not shown).
Discussion
Skin FE form a network responsible of the resilience and
elasticity of the tissue (Toonkool et al, 2001; Kielty et al,
2002). The main amorphous component of those fibers,
namely, elastin, was for a long time considered as an inert
matrix constituent, only contributing to the particular
rheologic property of elastin-containing tissues (Rosen-
bloom et al, 1993). Such assumption is no longer valid, and
tropoelastin, similarly to other connective tissue macro-
molecules, exhibits a modular structure that imparts
important biologic functions (Lapis and Timar, 2002). The
Figure 4
ED enhances melanoma cells invasiveness, MMP-2 activation, and decrease of TIMP-2 levels. (A) Invasion was assayed by embedding
melanoma cells within collagen lattices with or without k-elastin and counting invading cells 48 h later; data are means  SD of triplicate
experiments. po0.05 (control vs. treatment). (B) M3Da cells were cultured in collagen lattices containing or not k-elastin; gels and supernatants
were combined and MMP-1 was detected by western blot. (C) M3Da cells were cultured in collagen lattices containing or not k-elastin, and
conditioned media were analyzed by gelatin zymography. (D) Melanoma cells were grown into collagen lattices containing or not k-elastin; gels and
conditioned media were combined, and TIMP-2 expression was analyzed by western blot.
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Figure 5
ED-enhanced melanoma cells invasion is due to MMP-2 activation following S-Gal binding. (A) M3Da cells were cultured within collagen
lattices containing k-elastin in the absence or in the presence of rec.TIMP-2 or batimastat, and supernatants were analyzed by gelatin zymography.
(B) Invasion assays were performed with M3Da cells cultured within collagen lattices containing k-elastin, in the absence or in the presence of
rec.TIMP-2 or batimastat; data are means  SEM of triplicate experiments. po0.05 and po0.01 (k-elastin vs. treatment). (C) M3Da cells were
cultured within collagen lattices containing k-elastin in the absence or in the presence of anti-S-Gal or preimmune IgG; supernatants were analyzed
by gelatin zymography. Where indicated, the ligand-binding domain of EBP, VGVAPG, was included into collagen lattices instead of adding k-elastin.
(D) Invasion assays were performed with M3Da cells embedded within collagen lattices containing k-elastin, in the absence or in the presence of
anti-S-Gal or preimmune IgG. Where indicated, the ligand-binding domain of EBP, VGVAPG, was included into collagen gels instead of adding k-
elastin; data are means  SD of triplicate experiments. po0.05, k-elastin versus anti-S-Gal.
Figure 6
Identification of S-Gal and MMP in
human melanoma. Immunochemistry:
Positive immunostaining for S-Gal (A),
MMP-2 (B), and MT1-MMP (C) in mela-
noma cells at the invasive front of the
tumor.
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aim of our investigation was to explore the contribution of
ED in melanoma cells invasion through a three-dimensional
type I collagen matrix. We first examined, on a morphologic
basis, the alteration of FE associated with melanoma
progression. FE were totally absent within tumor mass
and intense fragmentation of those fibers was noticed at the
invasive front of the tumor. Elastolysis was dramatically
more pronounced in melanoma with a Breslow index of
greater than 5 mm and it was recently reported that
melanomas that lacked elastic tissue in their depth were
associated with a high death rate (Feinmesser et al, 2002).
The close spatial association between melanoma cells and
elastin was evidenced ultrastructurally, and intense frag-
mentation of elastic fibers was noticed in close contact to
tumor cells. We then undertook in vitro studies, using
melanoma cell lines with high and low tumorigenic potential,
to evaluate the influence of ED on MMP expression. Our
initial experiments were rather disappointing because ED,
contrary to that found with other cell types, lack any effect
on cell proliferation and MMP production. Nevertheless,
immobilization of those peptides to culture dishes specifi-
cally enhanced MMP-2 production, most importantly by the
highly invasive cell line. The influence of coating versus free
macromolecule in directing MMP expression has been
previously documented for fibronectin (Stanton et al, 1998).
The reasons for such differential effect on different cell types
are unclear, possibly relying on distinct elastin conformation
depending on its free or binding state or alternatively on the
nature of the S-Gal receptor system. Strikingly, a 59-kDa
molecular mass has been assigned to S-Gal by western blot
analysis of both melanoma cell lines (not shown); a similar
elastin receptor subunit has been described in Lewis lung
carcinoma cell line and B16 melanoma variants that was
implicated in the selective metastasis of those tumor cells to
the lung (Yusa et al, 1989). Thus, our in vitro assays
demonstrate that ED were able to stimulate the expression
of MMP-2 by melanoma cells. These effects were inhibited
by lactose, which was shown to dissociate the 67-kDa EBP
from the cell surface and to decrease its affinity for ED
(Duca et al, 2002). EBP is an ubiquitous protein either
involved in elastogenesis, acting as a tropoelastin chaper-
on, or involved as a recognition molecule for XGXXPG motif
present in ED. EBP was further identified as an alternative
S-Gal associated at the cell plasma membrane with two
subunits, a sialidase and a cathepsin A (Fu¨lo¨p and Larbi,
2002)
ED-mediated pro-MMP-2 expression in our melanoma
cell lines was not found associated with enzyme activation.
It is now well established that the activation of pro-MMP-2
is regulated by a complex mechanism involving the
formation of a trimolecular complex with MT1-MMP and
TIMP-2 (Murphy et al, 1999). An adjacent free active MT1-
MMP, through PEX oligomerization with TIMP-2 inhibited
MT1-MMP, was shown to catalyze pro-MMP-2 processing
to active enzyme. In some cell types, avb3-integrin has also
been described as a partner of the active matrix-degrading
complex (MMP-2/TIMP-2/MT1-MMP) (Deryugina et al,
2000, 2001). Although k-elastin could enhanced MT1-
MMP expression and induced its activation, those peptides
could also concomitantly stimulate TIMP-2 production by
highly invasive M3Da cells. The expression of avb3-integrin
by melanoma cells was not susceptible to k-elastin,
suggesting that it did not mediate ED effects. Elastin,
because of lacking the RGD sequence, did not interact
directly with integrin receptors (Kielty et al, 2002). Never-
theless, we cannot rule out an indirect interaction between
elastin and integrins through fibulin-5 as described by
Nakamura et al (2002). Thus, in experiments performed in a
two-dimensional environment, pro-MMP-2 activation did
not occur. In contrast, when either soluble ED or insoluble
elastin were incorporated within type I collagen gels, pro-
MMP-2 activation was significantly potentiated compared
to experiments performed in absence of elastin or in
presence of a nonspecific protein, that is, serum bovine
albumin (data not shown). Upregulation of MMP-2 activa-
tion paralleled an increased collagen invasiveness of
melanoma cells that can be abolished by batimastat and
TIMP-2. Those effects could be suppressed by lactose and
S-Gal antibody and also reproduced by VGVAPG, indicating
that S-Gal occupancy triggered enhanced melanoma
invasion, in vitro, by upregulating MMP-2 activation.
Interestingly, pro-MMP-2 processing to active enzyme
within ED-containing three-dimensional collagen environ-
ment was associated with a striking downregulation of
TIMP-2. We and others have previously reported a decrease
in TIMP-2 levels during the MMP-2 activation process
(Kurschat et al, 1999; Ntayi et al, 2001). The molecular
mechanism underlying such decrease in secreted TIMP-2
level is still unclear. Recently, Munshi et al, 2002 have
evoked the fact that this reduction in TIMP-2 levels could
result from MT1-MMP-mediated internalization of TIMP-2
and subsequent intracellular degradation in endosomes
and/or lysosomes.
Finally, the inhibitory effect of anti S-Gal antibody, which
recognizes EBP on ED-enhanced melanoma cell invasive-
ness, suggests the involvement of EBP in this process.
Interestingly, VGVAPG, a motif recognized by EBP, could
reproduce the MMP-2-mediated melanoma cell invasion
observed with k-elastin. Collectively, our data indicate that
contact between invasive melanoma cells and ED through
S-Gal occupancy could stimulate MT1-MMP and MMP-2
enzyme expression and activation, further facilitating their
invasion through a type I collagen matrix. Among MMP
displaying elastolytic activity, the best candidate is gelati-
nase A, that is, MMP-2 (Mecham et al, 1997), also
described as the main gelatinolytic enzyme in melanoma
(Kurschat et al, 1999). We hypothesized that in vivo, its
intense expression, together with its activator MT1-MMP, at
the invasive front of melanoma with a high Breslow index,
liberated ED following elastin degradation. These peptides
also increase MMP-2 production by human dermal fibro-
blasts (Brassart et al, 2001) and further stimulate fibroblasts
chemotaxis (Kamoun et al, 1995) and expression of both
collagenase-1 and stromelysin-1 (Brassart et al, 2001) in
addition to accelerate tumor angiogenesis (Nackman et al,
1996). Such effects make elastin and S-Gal as putative
targets to control melanoma progression.
Materials and Methods
For histologic and immunochemistry studies, all samples (paraffin-
embedded skin biopsy specimens) were collected retrospectively from
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the files of the laboratory of histiopathology Pol Bouin (Reims, France)
and institutional approval was obtained for all diagnostic purposes.
The two melanoma cell lines used in this study (M1Dor and M3Da)
were established from metastases of two patients with malignant
melanoma and have been previously characterized. These cells were
chosen in keeping with their different ability to grow in nude mice after
subcutaneous grafting. The percentage of tumor taken in nude mice
was 100% for M3Da and 26% for M1Dor (Berthier-Vergnes et al, 1985).
Tumor cell lines were grown as monolayer cultures in MacCoy’s 5A
medium supplemented with 1% L-glutamine, 5 mg per mL gentamicin,
and 10% fetal bovine serum (Gibco, Cergy-Pontoise, France) in a
humidified 95% air, 5% CO2 atmosphere at 371C. Their viability was
assessed by the trypan blue exclusion technique.
Reagents Gelatin, gelatin–Sepharose, lactose, anti-sheep IgG
secondary antibody, and goat anti-rabbit IgG fluorescein isothio-
cyanate (FITC) conjugate were purchased from Sigma (Saint
Quentin Fallavier, France). Human recombinant tissue inhibitor of
metalloproteinase (TIMP)-2 (rec.TIMP-2); mouse antibodies against
human MMP-1 (IM35L), MMP-2 (IM33L), MT1-MMP (IM57L), MT1-
MMP (114–1F2), TIMP-2 (IM11L), and integrin avb3 (LM609); and
sheep anti-human MMP-1 (PC311) were obtained from Calbio-
chem (VWR, Fontenay sous Bois, France). Peroxidase-conjugated
rabbit anti-mouse immunoglobulin was from Dako (Trappes,
France), and goat anti-mouse fluorescein-labeled secondary anti-
body was from Beckman Coulter (Marseille, France). Batimastat
was provided by British Biotech (Oxford, UK). Acid-soluble native
type I collagen was prepared from rat tail tendons as previously
described (Berton et al, 2000), insoluble elastin was prepared from
bovine ligamentum nuchae by hot alkali treatment, and its purity
was assessed by amino acid analysis. The lack of hexoses and
hexosamines was determined in the preparation (Jacob and
Hornebeck, 1985). Soluble k-elastin peptides (k-elastin) were
obtained from purified insoluble elastin by organo-alkaline hydro-
lysis. Peptides with an average molecular weight of 75 kDa were
isolated by gel permeation on Sephadex G-100.
Peptides synthesis and antibody preparation Peptides were
synthesized using 9-fluoromethoxycarbonyl (FMC) chemistry,
using a FMC-Val-resin (0.22 mEq/g). Coupling were performed
with FMC-amino acid-pentafluorophenyl esters (Pfb) (4 molar
excess). Each FMC deprotection step involved treatment with
20% piperidine/dimethylformamide for 10 min. Cleavage of the
peptide from the resin was achieved by 6 h of treatment with
trifluoroacetic acid water (95:5; vol/vol), followed by successive
washings of the resin with ether. Purity of peptides was confirmed
by HPLC and by fast atom bombardment mass spectrometry.
Either (VGVAPG)3 corresponding to the S-Gal recognizing
sequence in elastin (Hinek et al, 1993) or VVGSPSAQDEASPL
corresponding to the unique sequence from the alternatively
spliced form of human b-galactosidase (Privitera et al, 1998;
Fujimoto et al, 2000) was injected intraperitoneally to rabbits.
Antibodies were purified from antisera by protein A-TSK gel
(Amersham, France). Peptide-agarose affinity gels were prepared
by coupling peptides to Affigel 15 (Bio-Rad, France) according to
the manufacturer’s protocol. Antisera were applied onto peptide
Affigel column, and specific antibodies were eluted with 0.1 M
citrated buffer, pH 3.0. After neutralization, antibodies (designated
as anti-elastin and anti-S-Gal, respectively) were dialyzed over-
night with phosphate-buffered saline (pH 7.4). This antibody
recognizes human, sheep, and bovine S-Gal.
Elastin-coated plates were prepared as previously described
(Jung et al, 1999). Briefly, 24-well culture plates were coated either
with k-elastin or with VGVAPG at a final concentration of 50 or 200
mg/cm2, respectively, and air-dried overnight at room temperature.
The wells were then saturated with 1% (w/v) bovine serum albumin
(BSA) in phosphate-buffered saline (PBS) for 1 h at room
temperature, washed with PBS, and used soon after.
Preparation of conditioned medium and membrane extracts A
total of 100,000 cells per dish suspended in 1 mL culture medium
were initially seeded in 24-well plastic plates (Corning, VWR
International, West Chester, PA) or coated with k-elastin or
VGVAPG peptides. Cells were then washed three times with PBS
and cultured in serum-free MacCoy’s 5A for 24 h. Conditioned
media were collected, centrifuged (1000  g), aliquoted, and
stored at 801C until use.
Membrane extracts were obtained following treatment of the
cells with 1.5% Triton X-114 in proteinase inhibitors containing TBS
(50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 2 mM CaCl2, and 2 mM
MgCl2) for 15 min at 41C. Lysates were centrifuged (10,000  g, 2
min), the supernatants were placed at 371C for 5 min, and the
aqueous phase was separated after centrifugation (5000  g, 1
min). As determined using the micro-BCA protein assay (Pierce,
Rockford, IL), protein concentrations of lysates from the two
melanoma cell lines did not show significant differences. Samples
were then mixed with 20 mL of gelatin-Sepharose for 30 min at 41C
to concentrate gelatinases and eluted with nonreducing Laemmli
buffer 2  .
Zymography and reverse zymography Melanoma cells were
seeded on plastic or k-elastin- or VGVAPG-coated plates and
serum-free conditioned medium, and membrane-cell extracts were
harvested. In some experiments, cells were preincubated with
lactose (10 mM) for 1 h, before seeding. Samples were eluted with
nonreducing Laemmli buffer and separated through a 10% sodium
dodecyl sulfate (SDS)-polyacrylamide gel containing 1 mg per mL
gelatin as substrate. Following electrophoresis, the gels were
washed in 2.5% Triton X-100 for 1 h at room temperature; further
incubated at 371C overnight in 50 mM Tris-HCl, 5 mM CaCl2, 200
mM NaCl (pH 7.6); stained with Coomassie blue G-250 (0.1%); and
destained in methanol/acetic acid/water (20/10/70; vol/vol/vol).
Gelatinolytic activity of latent (72 kDa) and activated (62 kDa)
MMP-2 was evidenced as white zones of lysis indicating gelatin
degrading activity. Gelatinase activity as detected by zymography
was quantified by an automated image analyzer (Vuilber-Lourmat)
as described previously (Buisson-Legendre et al, 1999). Linear
range of enzyme activity was assessed using recombinant MMP-2
as standard. Linearity was between 10 and 200 pg of enzyme.
Reverse zymography was also performed to identified the
TIMP; conditioned media were electrophoresed through a 15%
polyacrylamide-SDS gel polymerized with 0.1% gelatin and 20 ng
per mL of activated gelatinase A. After washing and overnight
incubation, TIMP-1 and TIMP-2 appeared as dark bands at 28 and
21 kDa, respectively.
Western blot analysis and ELISA For MMP-1 and TIMP-2
analysis, collagen lattices (see below) and conditioned media were
homogenized by sonication in the presence of 10 mM ethylene-
diaminetetraacetate. Samples were then resolved on either a 10%
or a 15% SDS-polyacrylamide gel, respectively, in the presence of
dithiothreitol and by heating at 951C for 5 min. For MT1-MMP
detection, 3  106 cells were seeded either on plastic or on
k-elastin-coated dishes for 48 h in serum-free medium; scraped for
30 min on ice with a 20-mM Tris-HCl buffer, pH 7.4, containing 1%
SDS and 10 mM ethylenediaminetetraacetate (Tris-buffer); and
homogenized by sonication. The homogenates were centrifuged
(10,000  g) for 1 h at 41C, and MT1-MMP present in the soluble
fraction was separated on a 10% SDS-polyacrylamide gel under
reducing condition. The proteins were then transferred to poly-
vinylidenedifluoride membranes (Millipore, Bedford, MA) using a
Trans-blot cell system (Bio-Rad, Marnes-la-Coquette, France), and
blots were saturated overnight with 5% BSA/Tris-buffered saline
containing 5% Tween 20. After extensive washings with Tris-
buffered saline containing 5% Tween 20, membranes were
incubated at 201C in 1% BSA/Tris-buffered saline containing 5%
Tween 20 with primary antibodies against human TIMP-2 (5 mg/mL)
for 2 h, human MMP-1 (1/1000) for 2 h, or MT1-MMP (10 mg/mL) for
3 h. After incubation either with anti-sheep IgG (1/10,000) or with
anti-mouse IgG (1/2000), immune complexes were detected with
the enhanced chemiluminescence system according to the
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manufacturer’s instructions (Amersham Pharmacia Biotech, Buck-
inghamshire, UK).
For quantification of total MMP-1 protein levels, conditioned
media were pooled with cell extracts, and 100 mL was incubated in
multiwell plates (Amersham Pharmacia Biotech) precoated with
specific antibodies against MMP-1. Antigen–antibody complexes
were measured after incubation with horseradish peroxidase-
conjugated anti-MMP-1 Fab fragment. 3,30,5,50-Tetramethylbenzi-
dine was used as a substrate to evaluate peroxidase activity. Serial
dilutions of human recombinant MMP-1 were used as internal
standards.
Immunocytochemistry To investigate the expression of avb3-
integrin, melanoma cell lines were plated on 24-well dishes for
24 h. Cells were washed three times in PBS, fixed with 4%
paraformaldehyde for 10 min at 201C, and treated with 0.1% Triton
X-100. The coverslips were then saturated for 30 min with 3% BSA
in PBS. Cells were subsequently incubated with a mouse mono-
clonal anti-human avb3 integrin antibody for 45 min and with a goat
anti-mouse fluorescein-labeled secondary antibody for 45 min at
41C. As a negative control, the primary antibody was omitted.
For EBP immunostaining, melanoma cell lines were fixed in cold
methanol at 201C for 30 min, washed with PBS, and saturated
with a PBS solution containing 1% fetal calf serum and 1% normal
goat serum. Cells were then labeled with a polyclonal anti-S-Gal
recognizing EBP (20 mg/mL) and with a goat anti-rabbit FITC-
conjugated secondary antibody (1/40). As negative control, the
primary antibody was omitted. After washing, the slides were
mounted with a 0.1 M glycerol/Tris-HCl, pH 8.0 (vol/vol), solution
and observed under a fluorescence microscope (Zeiss/Fuji
Medical System).
Fluorescence-activated cell sorting analysis To investigate the
cell surface expression of avb3-integrin on human melanoma cell
lines, cells were detached from the culture flask (elastin-coated or
not) with 20 mM ethylenediaminetetraacetate. Cells were incu-
bated with primary antibody against avb3-integrin (5 mg/mL in PBS
containing 1% BSA and 0.02% sodium azide) for 30 min at 41C
and then with anti-mouse IgG F(ab0)2 conjugated with FITC (Dako,
Trappes, France) for 45 min at 41C. FITC-labeled cells were
analyzed on a FACStar flow cytometer. Negative controls con-
sisted of omitting the primary antibody or of staining cells with a
murine IgG. Experiments were performed at least two times.
Transwell invasion assays Native type I collagen was sterilized
by overnight soaking in 70% ethanol, dissolved in 0.018 M acetic
acid, and stored at 41C as stock solution (2 mg/mL). For lattice
preparation, collagen was mixed with Hank’s balanced salts (1  )
and NaOH (0.1 N) in an 8:1:1 (vol/vol/vol) ratio at 41C to a final
concentration of 1 mg per mL in serum-free medium, and 1  105
melanoma cells were added. The suspension was allowed to
polymerize for 45 min at 371C in a 5% CO2 atmosphere, before
adding serum-free medium. The lattices were incubated for 48 h at
371C, and conditioned media were collected and stored at 801C
until use. To prepare lattices containing elastin-derived peptides,
k-elastin (50 mg/mL) or VGVAPG (200 mg/mL) was added to 1 mg
per mL neutral collagen solution, before inclusion of melanoma
cells and gel polymerization. The invasion of melanoma cells in
Transwell (Corning, VWR International.) was analyzed under
serum-free conditions as described previously. Briefly, 1  105
cells were embedded into 0.5 mL of collagen gel (1 mg/mL) and
filled into the inner chamber of the Transwell with 0.5 mL of
MacCoy’s 5A medium. The outer chamber was filled with
MacCoy’s 5A medium supplemented with 10% FCS and 2%
BSA as chemoattractant. Following incubation for 48 h, cells that
migrated to the membrane’s undersurface were detached with a
trypsin solution and counted.
For blocking experiments, cells were embedded into collagen
gels with TIMP-2 (80 ng/mL), batimastat (1 mM), S-Gal (300 mg/mL),
anti S-Gal (1/100), or IgG (1/100) as control, and migrating cells
were quantified 48 h later.
Histology and immunohistochemistry To study morphologic
interactions between melanoma and dermal elastin in vivo, we
selected a series of formalin-fixed and paraffin-embedded tissue of
melanocytic skin lesions including nine primary melanomas (five
with a Breslow index p0.45 mm and four with a Breslow index
between 2.5 and 5.2 mm) and five nevi (four compound nevi and
one intradermal nevus) or normal human skin (as control). All skin
specimens provided from a usually nonexposed body area (trunk,
thigh, leg) except in one case (one melanoma located on the arm).
FE were stained with orcein and morphologically analyzed, within
and at the immediate periphery of tumor and lymphocytic infiltrates
on a representative section containing the most developed tumor.
Monoclonal antibodies against MMP-2 (1/100), MT1-MMP (15
mg/mL), and anti-S-Gal (1/10) were used for immunohistologic
studies on 4-mm deparaffinized skin sections. The streptavidin-
biotin (LSAB) method was performed with a kit according to
manufacturer instructions (Dako LSAB kit, HRP). Slides were
incubated with the primary antibody diluted in PBS, pH 7.5,
containing 1% bovine serum albumin overnight at 41C. Biotinylated
anti-rabbit and anti-mouse secondary antibodies were incubated
for 20 min at room temperature. After being washed, they were
incubated in streptavidin-labeled peroxidase for 20 min, and the
antibody reaction was further visualized using 3% 3-amino-9-
ethylcarbazole in N,N-dimethylformamide. Sections were counter-
stained with Meyer’s hematoxylin. As negative control, the first
antibody was omitted.
Transmission electron microscopy For transmission electron
microscopy, a 1-mm3 skin biopsy specimen from the invasive front
of melanoma with a Breslow index of greater than 5 mm was taken,
embedded into paraffin, and postfixed with osmium tetraoxide.
After inclusion, sections of 0.5 mm were cut and stained with
methylene blue azur II. Ultrathin sections were cut with a
ultramicrotome and stained with uranylacetate and lead citrate.
These sections were then examined under an electron microscope
(Hitachi H300, 75 kV).
Statistical analysis Experiments were performed at least twice in
triplicate. Data are reported as means  SD. Student’s t test was
used to determine differences between control and k-elastin-
treated samples. Data were considered to be significant when p
was less than 0.05 or 0.01.
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